Nebula Research & Development’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-75,140
Closed -$353K 1017
2024
Q4
$353K Sell
75,140
-6,595
-8% -$31K 0.04% 672
2024
Q3
$292K Buy
+81,735
New +$292K 0.03% 725